Inrad Optics, Inc.
INRD
$1.09
$0.000.00%
| Weiss Ratings | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | B- | |||
| Rating Factors | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.05 | |||
| Price History | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.40% | |||
| 30-Day Total Return | -27.33% | |||
| 60-Day Total Return | -9.17% | |||
| 90-Day Total Return | -12.80% | |||
| Year to Date Total Return | -12.80% | |||
| 1-Year Total Return | -7.63% | |||
| 2-Year Total Return | -28.29% | |||
| 3-Year Total Return | 81.67% | |||
| 5-Year Total Return | -39.44% | |||
| 52-Week High % Change | -32.72% | |||
| 52-Week Low % Change | 142.22% | |||
| Price | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.62 | |||
| 52-Week Low Price | $0.45 | |||
| 52-Week Low Price (Date) | Aug 08, 2023 | |||
| 52-Week High Price (Date) | Sep 20, 2023 | |||
| Valuation | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 15.55M | |||
| Enterprise Value | 16.22M | |||
| Price/Earnings (TTM) | 6.84 | |||
| Earnings Per Share (TTM) | 0.16 | |||
| Earnings Per Share Growth | 1,997.37% | |||
| Price/Earnings To Growth | 0.00 | |||
| Price/Sales (TTM) | 1.44 | |||
| Price/Book (Q) | 2.37 | |||
| Enterprise Value/Revenue (TTM) | 1.26 | |||
| Price | $1.09 | |||
| Enterprise Value/EBITDA (TTM) | 7.63 | |||
| Enterprise Value/EBIT | 8.94 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 17.06M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 201 767 1910 | |||
| Address | 181 Legrand Avenue Northvale, NJ 07647 | |||
| Website | www.inradoptics.com | |||
| Country | United States | |||
| Year Founded | 1973 | |||
| Profitability | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 14.04% | |||
| Profit Margin | 20.66% | |||
| Management Effectiveness | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 10.90% | |||
| Return on Equity | 52.24% | |||
| Income Statement | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 12.91M | |||
| Total Revenue (TTM) | 12.91M | |||
| Revenue Per Share | $0.76 | |||
| Gross Profit (TTM) | 4.93M | |||
| EBITDA (TTM) | 2.12M | |||
| EBIT (TTM) | 1.81M | |||
| Net Income (TTM) | 2.67M | |||
| Net Income Avl. to Common (TTM) | 2.67M | |||
| Total Revenue Growth (Q YOY) | 4.39% | |||
| Earnings Growth (Q YOY) | 2,756.65% | |||
| EPS Diluted (TTM) | 0.16 | |||
| EPS Diluted Growth (Q YOY) | -- | |||
| Balance Sheet | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.97M | |||
| Cash Per Share (Q) | $0.17 | |||
| Total Current Assets (Q) | 8.38M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 6.55M | |||
| Current Ratio (Q) | 3.675 | |||
| Book Value Per Share (Q) | $0.46 | |||
| Total Assets (Q) | 11.71M | |||
| Total Current Liabilities (Q) | 2.28M | |||
| Total Debt (Q) | 3.26M | |||
| Total Liabilities (Q) | 5.16M | |||
| Total Common Equity (Q) | 6.55M | |||
| Cash Flow | INRD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -363.10K | |||
| Cash from Financing (TTM) | -27.60K | |||
| Net Change in Cash (TTM) | 969.80K | |||
| Levered Free Cash Flow (TTM) | 374.70K | |||
| Cash from Operations (TTM) | 1.36M | |||
